Arrow Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-660
| Closed | -$207K | – | 338 |
|
|
2019
Q2 | $207K | Hold |
660
| – | – | 0.04% | 168 |
|
|
2019
Q1 | $271K | Buy |
660
+600
| +1,000% | +$246K | 0.06% | 156 |
|
|
2018
Q4 | $22K | Hold |
60
| – | – | 0.01% | 256 |
|
|
2018
Q3 | $24K | Hold |
60
| – | – | 0.01% | 266 |
|
|
2018
Q2 | $21K | Hold |
60
| – | – | ﹤0.01% | 255 |
|
|
2018
Q1 | $21K | Buy |
+60
| New | +$21K | ﹤0.01% | 262 |
|
|
2017
Q4 | – | Sell |
-100
| Closed | -$45K | – | 339 |
|
|
2017
Q3 | $45K | Buy |
+100
| New | +$45K | 0.01% | 218 |
|
|
2014
Q2 | – | Sell |
-40
| Closed | -$12K | – | 358 |
|
|
2014
Q1 | $12K | Buy |
40
+5
| +14% | +$1.5K | ﹤0.01% | 274 |
|
|
2013
Q4 | $10K | Buy |
35
+20
| +133% | +$5.71K | ﹤0.01% | 266 |
|
|
2013
Q3 | $5K | Buy |
+15
| New | +$5K | ﹤0.01% | 304 |
|